NSD2 is a conserved driver of metastatic prostate cancer progression

被引:75
作者
Aytes, Alvaro [1 ,2 ,3 ]
Giacobbe, Arianna [1 ,4 ]
Mitrofanova, Antonina [5 ,6 ]
Ruggero, Katia [2 ,3 ]
Cyrta, Joanna [7 ]
Arriaga, Juan [1 ,4 ]
Palomero, Luis [2 ,3 ]
Farran-Matas, Sonia [2 ,3 ]
Rubin, Mark A. [7 ,8 ]
Shen, Michael M. [1 ,4 ,5 ,9 ,10 ]
Califano, Andrea [5 ,10 ,11 ]
Abate-Shen, Cory [1 ,4 ,5 ,10 ,12 ]
机构
[1] Columbia Univ, Dept Urol, Irving Med Ctr, 160 Ft Washington Ave, New York, NY 10032 USA
[2] Bellvitge Inst Biomed Res, Catalan Inst Oncol, Program Mol Mech & Expt Therapeut Oncol ONCOBell, Barcelona 08908, Spain
[3] Bellvitge Inst Biomed Res, Catalan Inst Oncol, Program Canc Therapeut Resistance ProCURE, Barcelona 08908, Spain
[4] Columbia Univ, Irving Med Ctr, Dept Med, 630W 168th St, New York, NY 10032 USA
[5] Columbia Univ, Irving Med Ctr, Dept Syst Biol, 1130 St Nicholas Ave, New York, NY 10032 USA
[6] Rutgers State Univ, Dept Hlth Informat, Rutgers Sch Hlth Profess, 65 Bergen St, Newark, NJ 07101 USA
[7] Weill Cornell Med, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA
[8] Univ Bern, Dept BioMed Res, Murtenstr 35, CH-3008 Bern, Switzerland
[9] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, 701 West 168th St, New York, NY 10032 USA
[10] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, 1130 St Nicholas Ave, New York, NY 10032 USA
[11] Columbia Univ, Dept Biochem & Mol Biophys, Irving Med Ctr, 701 West 168th St, New York, NY 10032 USA
[12] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, 630W 168th St, New York, NY 10032 USA
关键词
HISTONE METHYLTRANSFERASE; MOUSE MODEL; EXPRESSION; RESISTANCE; BIOLOGY; CLASSIFICATION; MUTATIONS; THERAPIES; MECHANISM; EVOLUTION;
D O I
10.1038/s41467-018-07511-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Deciphering cell-intrinsic mechanisms of metastasis progression in vivo is essential to identify novel therapeutic approaches. Here we elucidate cell-intrinsic drivers of metastatic prostate cancer progression through analyses of genetically engineered mouse models (GEMM) and correlative studies of human prostate cancer. Expression profiling of lineage-marked cells from mouse primary tumors and metastases defines a signature of de novo metastatic progression. Cross-species master regulator analyses comparing this mouse signature with a comparable human signature identifies conserved drivers of metastatic progression with demonstrable clinical and functional relevance. In particular, nuclear receptor binding SET Domain Protein 2 (NSD2) is robustly expressed in lethal prostate cancer in humans, while its silencing inhibits metastasis of mouse allografts in vivo. We propose that cross-species analysis can elucidate mechanisms of metastasis progression, thus providing potential additional therapeutic opportunities for treatment of lethal prostate cancer.
引用
收藏
页数:14
相关论文
共 63 条
[1]   The Molecular Taxonomy of Primary Prostate Cancer [J].
Abeshouse, Adam ;
Ahn, Jaeil ;
Akbani, Rehan ;
Ally, Adrian ;
Amin, Samirkumar ;
Andry, Christopher D. ;
Annala, Matti ;
Aprikian, Armen ;
Armenia, Joshua ;
Arora, Arshi ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barbieri, Christopher E. ;
Bauer, Thomas ;
Benz, Christopher C. ;
Bergeron, Alain ;
Beroukhim, Rameen ;
Berrios, Mario ;
Bivol, Adrian ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
dos Reis, Rodolfo Borges ;
Boutros, Paul C. ;
Bowen, Jay ;
Bowlby, Reanne ;
Boyd, Jeffrey ;
Bradley, Robert K. ;
Breggia, Anne ;
Brimo, Fadi ;
Bristow, Christopher A. ;
Brooks, Denise ;
Broom, Bradley M. ;
Bryce, Alan H. ;
Bubley, Glenn ;
Burks, Eric ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Canes, David ;
Carlotti, Carlos G. ;
Carlsen, Rebecca ;
Carmel, Michel ;
Carroll, Peter R. ;
Carter, Scott L. ;
Cartun, Richard ;
Carver, Brett S. ;
Chan, June M. ;
Chang, Matthew T. ;
Chen, Yu .
CELL, 2015, 163 (04) :1011-1025
[2]   Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making [J].
Abida, Wassim ;
Armenia, Joshua ;
Gopalan, Anuradha ;
Brennan, Ryan ;
Walsh, Michael ;
Barron, David ;
Danila, Daniel ;
Rathkopf, Dana ;
Morris, Michael ;
Slovin, Susan ;
McLaughlin, Brigit ;
Curtis, Kristen ;
Hyman, David M. ;
Durack, Jeremy C. ;
Solomon, Stephen B. ;
Arcila, Maria E. ;
Zehir, Ahmet ;
Syed, Aijazuddin ;
Gao, Jianjiong ;
Chakravarty, Debyani ;
Vargas, Hebert Alberto ;
Robson, Mark E. ;
Vijai, Joseph ;
Offit, Kenneth ;
Donoghue, Mark T. A. ;
Abeshouse, Adam A. ;
Kundra, Ritika ;
Heins, Zachary J. ;
Penson, Alexander V. ;
Harris, Christopher ;
Taylor, Barry S. ;
Ladanyi, Marc ;
Mandelker, Diana ;
Zhang, Liying ;
Reuter, Victor E. ;
Kantoff, Philip W. ;
Solit, David B. ;
Berger, Michael F. ;
Sawyers, Charles L. ;
Schultz, Nikolaus ;
Scher, Howard I. .
JCO PRECISION ONCOLOGY, 2017, 1 :1-26
[3]   Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes [J].
Aggarwal, Rahul ;
Zhang, Tian ;
Small, Eric J. ;
Armstrong, Andrew J. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (05) :719-726
[4]  
[Anonymous], [No title captured]
[5]   Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers [J].
Aparicio, Ana M. ;
Shen, Li ;
Tapia, Elsa Li Ning ;
Lu, Jing-Fang ;
Chen, Hsiang-Chun ;
Zhang, Jiexin ;
Wu, Guanglin ;
Wang, Xuemei ;
Troncoso, Patricia ;
Corn, Paul ;
Thompson, Timothy C. ;
Broom, Bradley ;
Baggerly, Keith ;
Maity, Sankar N. ;
Logothetis, Christopher J. .
CLINICAL CANCER RESEARCH, 2016, 22 (06) :1520-1530
[6]   Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer [J].
Asangani, Irfan A. ;
Ateeq, Bushra ;
Cao, Qi ;
Dodson, Lois ;
Pandhi, Mithil ;
Kunju, Lakshmi P. ;
Mehra, Rohit ;
Lonigro, Robert J. ;
Siddiqui, Javed ;
Palanisamy, Nallasivam ;
Wu, Yi-Mi ;
Cao, Xuhong ;
Kim, Jung H. ;
Zhao, Meng ;
Qin, Zhaohui S. ;
Iyer, Mathew K. ;
Maher, Christopher A. ;
Kumar-Sinha, Chandan ;
Varambally, Sooryanarayana ;
Chinnaiyan, Arul M. .
MOLECULAR CELL, 2013, 49 (01) :80-93
[7]   Prostate cancer [J].
Attard, Gerhardt ;
Parker, Chris ;
Eeles, Ros A. ;
Schroder, Fritz ;
Tomlins, Scott A. ;
Tannock, Ian ;
Drake, Charles G. ;
de Bono, Johann S. .
LANCET, 2016, 387 (10013) :70-82
[8]   Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy [J].
Aytes, Alvaro ;
Mitrofanova, Antonina ;
Lefebvre, Celine ;
Alvarez, Mariano J. ;
Castillo-Martin, Mireia ;
Zheng, Tian ;
Eastham, James A. ;
Gopalan, Anuradha ;
Pienta, Kenneth J. ;
Shen, Michael M. ;
Califano, Andrea ;
Abate-Shen, Cory .
CANCER CELL, 2014, 25 (05) :638-651
[9]   ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer [J].
Aytes, Alvaro ;
Mitrofanova, Antonina ;
Kinkade, Carolyn Waugh ;
Lefebvre, Celine ;
Lei, Ming ;
Phelan, Vanessa ;
LeKaye, H. Carl ;
Koutcher, Jason A. ;
Cardiff, Robert D. ;
Califano, Andrea ;
Shen, Michael M. ;
Abate-Shen, Cory .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (37) :E3506-E3515
[10]   Punctuated Evolution of Prostate Cancer Genomes [J].
Baca, Sylvan C. ;
Prandi, Davide ;
Lawrence, Michael S. ;
Mosquera, Juan Miguel ;
Romanel, Alessandro ;
Drier, Yotam ;
Park, Kyung ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Ghandi, Mahmoud ;
Van Allen, Eliezer ;
Kryukov, Gregory V. ;
Sboner, Andrea ;
Theurillat, Jean-Philippe ;
Soong, T. David ;
Nickerson, Elizabeth ;
Auclair, Daniel ;
Tewari, Ashutosh ;
Beltran, Himisha ;
Onofrio, Robert C. ;
Boysen, Gunther ;
Guiducci, Candace ;
Barbieri, Christopher E. ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Carter, Scott L. ;
Saksena, Gordon ;
Voet, Douglas ;
Ramos, Alex H. ;
Winckler, Wendy ;
Cipicchio, Michelle ;
Ardlie, Kristin ;
Kantoff, Philip W. ;
Berger, Michael F. ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Elemento, Olivier ;
Getz, Gad ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Garraway, Levi A. .
CELL, 2013, 153 (03) :666-677